A phase I clinical and pharmacokinetic study of paclitaxel liposome infused in non-small cell lung cancer patients with malignant pleural effusions

Toxicity and response criteria of the Eastern Cooperative Oncology Group

Martin M. Oken, Richard H. Creech, Douglass C. Tormey et al. · American Journal of Clinical Oncology · 1982 · 11.6K citations

Pharmacy, Oncology, Medical Oncology +8

Phase II Study of Taxol in Patients With Untreated Advanced Non-Small-Cell Lung Cancer

William K. Murphy, Frank V. Fossella, R Winn et al. · JNCI Journal of the National Cancer Institute · 1993 · 431 citations

Medicine, Oncology, Pharmacology +16

Complement Activation by Cremophor EL as a Possible Contributor to Hypersensitivity to Paclitaxel: an In Vitro Study

János Szebeni, Carl R. Alving, Franco M. Muggia · JNCI Journal of the National Cancer Institute · 1998 · 344 citations

Life Sciences, Immunology, Oncology +15

Phase II Study of Taxol, Merbarone, and Piroxantrone in Stage IV Non-Small-Cell Lung Cancer: The Eastern Cooperative Oncology Group Results

A. Y. Chang, K. Kim, John H. Glick et al. · JNCI Journal of the National Cancer Institute · 1993 · 339 citations

Medicine, Oncology, Pharmacology +12

Phase I trial of intraperitoneal taxol: a Gynecoloic Oncology Group study.

Maurie Markman, Eric K. Rowinsky, Thomas B. Hakes et al. · Journal of Clinical Oncology · 1992 · 314 citations

Pharmacy, Oncology, Pharmacology +17